# Two-Day CPET Across ME/CFS Severity Levels

**Authors:** C Linda Mc van Campen, Peter C Rowe, Frans C Visser
**Journal:** Healthcare (Basel), 2020, Vol. 8(3), Article 192
**DOI:** 10.3390/healthcare8030192
**PMID:** 32629923
**PMCID:** PMC7551790
**Publication Date:** June 30, 2020

## Key Points

- **Severity comparison study:** Examined how 2-day CPET patterns differ across mild, moderate, and severe ME/CFS
- **Female-only cohort:** n=82 females (31 mild, 31 moderate, 20 severe)
- **All severity levels show Day 1→Day 2 decline:** Universal PEM response across spectrum
- **Severity correlates with decline magnitude:** Severe patients showed largest deterioration

## Primary Findings

### All Severity Groups Showed Significant Day 1 to Day 2 Declines In:

1. Peak VO2 (maximal oxygen consumption)
2. VO2 at VT (oxygen consumption at ventilatory/anaerobic threshold)
3. Peak workload (maximum watts achieved)
4. Workload at VT (watts at anaerobic threshold)

### Severity-Dependent Patterns:

**Severe ME/CFS:**
- **Largest decline in peak workload:** -19% from Day 1 to Day 2
- Most pronounced post-exertional deterioration
- Demonstrates worst recovery capacity

**Moderate ME/CFS:**
- Intermediate decline magnitude
- Clear PEM response but less severe than severe group

**Mild ME/CFS:**
- Smallest decline magnitude (but still significant)
- Still demonstrates objective PEM, just less pronounced

### Key Implication:
Two-day CPET decline magnitude correlates with clinical severity classification and could serve as objective severity grading tool.

## Methodology

- Two-day cardiopulmonary exercise testing protocol
- 24-hour interval between tests
- Cycle ergometer
- Measured parameters:
  - Peak VO2
  - VO2 at VT
  - Peak workload (watts)
  - Workload at VT
  - Heart rate
- Female-only cohort (reduces sex-based variability)

## Acronym Definitions

- ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- CPET: Cardiopulmonary Exercise Test
- VO2: Oxygen consumption (volume of O2)
- VT: Ventilatory Threshold (anaerobic threshold)

## Certainty Assessment

- **Study Quality:** High
  - Good sample size (n=82)
  - Appropriate severity stratification
  - Objective physiological measures
  - Peer-reviewed publication
- **Sample Size:** n=82 (31 mild, 31 moderate, 20 severe) - well-balanced across groups
- **Replication:** Consistent with other 2-day CPET studies (Lim 2020, Keller 2024)
- **Conflicts of Interest:** None apparent
- **Limitations:**
  - Female-only cohort (may not generalize to males)
  - Cycle ergometer only
  - 24-hour interval (may miss longer-delayed PEM)
  - Severity classification methodology not fully detailed in abstract
  - Smaller severe group (n=20 vs. 31 mild, 31 moderate)

## Clinical Implications

1. **Objective Severity Grading:** 2-day CPET decline magnitude could objectively classify ME/CFS severity
   - Larger Day 1→Day 2 decline = more severe disease

2. **Universal PEM Response:** Even mild ME/CFS shows measurable post-exertional impairment
   - Validates PEM as core feature across spectrum

3. **Dose-Response by Baseline Severity:**
   - Severe patients: Same exertion "dose" produces larger impairment "response"
   - Suggests lower physiological reserve in severe disease

4. **Activity Limitation Stratification:**
   - Severe: Most restricted activity tolerance
   - Moderate: Intermediate tolerance
   - Mild: Highest tolerance (but still impaired vs. healthy)

5. **Monitoring Disease Progression:** Serial 2-day CPET could track worsening or improvement

## Relevance to Crash Severity Classification

**Critical for stratified pacing guidance:**

This study shows that:
- **Same exertion intensity produces different crash severity depending on baseline disease severity**
- Severe ME/CFS: -19% peak workload decline
- Mild/Moderate: Smaller declines (exact percentages not in abstract)

**Implication:** Pacing recommendations must be severity-stratified. What causes a mild crash in mild ME/CFS might cause a severe crash in severe ME/CFS.

**Integration with Chapter 14b:**
- Mild-moderate patients can tolerate higher baseline activity
- BUT still must respect energy limits
- Crash severity dose-response exists within each severity category
